Revenue growth will increase because spinal procedure volumes will be in higher demand, while extremities surgeries will remain strong, according to the report. Companies should expect to continue facing pressure to reduce prices, especially for hip and knee implants, and there will be stricter regulatory scrutiny which could lead to fewer new products in the coming year.
Of the leading orthopedic and spine device companies, Stryker will be the most successful because of the company’s ability to diversify products, according to the report.
Read full coverage from Bloomberg Businessweek on William Blair & Co.’s forecast for the orthopedic device market.
Read more coverage on orthopedic and spine device companies:
– 5 Recent Orthopedic and Spine Device Patent Infringement Cases
– Theken Spine Receives Grant for Equipment Purchasing
– Millennium Research Group Outlook for Minimally Invasive Spinal Fusion Market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.